title: Epstein-barr virus-induced hemophagocytic lymphohistiocytosis.
abstract: Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment.
authors: Mofid, Children's Hospital, shahid beheshti University of Medical Sciences, Tehran, Iran.
authors: K
authors: K
authors: Goudarzipour
authors: Mofid, Children's Hospital, shahid beheshti University of Medical Sciences, Tehran, Iran.
authors: M
authors: M
authors: Kajiyazdi
authors: Masih Daneshvari Hospital, shahid beheshti University of Medical Sciences, Tehran, Iran.
authors: A
authors: A
authors: Mahdaviyani
keywords: Epstein - Barr virus; Etanercept; Hemophagocytic lymphohistiocytosis; Infectious mononucleosis; Systemic inflammatory response syndrome; X-Linked lymphoproliferative disease